Trial Information
Inclusion Criteria:
- Patients with CRLM
- Surgery: resection and/or ablation
- preoperative chemotherapy and/or biological agents are allowed
- postoperative chemotherapy and/or biological agents are allowed
- simultaneous colorectal resection is allowed
Exclusion Criteria:
- primary liver cancer
- benign liver tumors
- pregnancy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
overall survival
Outcome Time Frame:
5 years
Safety Issue:
No
Authority:
Belgium: Ethics Committee
Study ID:
CRLM-MILS
NCT ID:
NCT01356706
Start Date:
October 2002
Completion Date:
July 2012
Related Keywords:
- Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators
- liver metastases
- colorectal cancer
- surgery
- prognosis
- Colorectal Neoplasms